Cargando…
Seprafilm(®) adhesion barrier: (2) a review of the clinical literature on intraabdominal use
This study seeks to provide a review of the clinical data published as of July 2011 concerning the postsurgical adhesion barrier, Seprafilm (chemically modified hyaluronic acid and carboxymethylcelulose; Genzyme Corporation, Cambridge, MA). Included articles detail the application of Seprafilm for i...
Autores principales: | Diamond, Michael P., Burns, Ellen L., Accomando, Beverly, Mian, Sadiqa, Holmdahl, Lena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401301/ https://www.ncbi.nlm.nih.gov/pubmed/22837733 http://dx.doi.org/10.1007/s10397-012-0742-8 |
Ejemplares similares
-
Seprafilm® adhesion barrier: (1) a review of preclinical, animal, and human investigational studies
por: Diamond, Michael P., et al.
Publicado: (2012) -
A Misleading Meta-analysis of Seprafilm
por: Holmdahl, Lena
Publicado: (2008) -
Seprafilm® Application Method in Laparoscopic Surgery
por: Hong, Mun-Kun, et al.
Publicado: (2017) -
Is Seprafilm valuable in infant cardiac redo procedures?
por: Lefort, Bruno, et al.
Publicado: (2015) -
Comparison of Intraperitoneal Honey and Sodium Hyaluronate-Carboxymethylcellulose (Seprafilm™) for the Prevention of Postoperative Intra-Abdominal Adhesions
por: Emre, Arif, et al.
Publicado: (2009)